BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9759839)

  • 1. CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation.
    Tangye SG; Phillips JH; Lanier LL; de Vries JE; Aversa G
    J Immunol; 1998 Oct; 161(7):3249-55. PubMed ID: 9759839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148.
    Tangye SG; Wu J; Aversa G; de Vries JE; Lanier LL; Phillips JH
    J Immunol; 1998 Oct; 161(8):3803-7. PubMed ID: 9780142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.
    Baker JE; Majeti R; Tangye SG; Weiss A
    Mol Cell Biol; 2001 Apr; 21(7):2393-403. PubMed ID: 11259588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling.
    Lin J; Weiss A
    J Cell Biol; 2003 Aug; 162(4):673-82. PubMed ID: 12913111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
    Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
    J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
    Moodycliffe AM; Maiti S; Ullrich SE
    J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
    J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4-mediated signals induce T cell dysfunction in vivo.
    Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
    J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies recognizing CD24 LAP epitope on human T cells enhance CD28 and IL-2 T cell proliferation.
    Salamone MC; Rosselot C; Salamone GV; Barboza M; Kado M; Fainboim L
    J Leukoc Biol; 2001 Feb; 69(2):215-23. PubMed ID: 11272271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the association between PSTPIP and CD2 in murine T cells.
    Bai Y; Ding Y; Spencer S; Lasky LA; Bromberg JS
    Exp Mol Pathol; 2001 Oct; 71(2):115-24. PubMed ID: 11599917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
    J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic shared antigen-2: a novel cell surface marker associated with T cell differentiation and activation.
    Berzins SP; Davey GM; Randle-Barrett ES; Malin MA; Classon BJ; Fraser S; Boyd RL
    J Immunol; 1999 May; 162(9):5119-26. PubMed ID: 10227982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes.
    Joo HG; Goedegebuure PS; Sadanaga N; Nagoshi M; von Bernstorff W; Eberlein TJ
    J Leukoc Biol; 2001 Apr; 69(4):555-64. PubMed ID: 11310841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
    Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
    J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.